Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Olivier Thirion"'
Autor:
Philippe-Henri Secretan, Victoire Vieillard, Olivier Thirion, Maxime Annereau, Hassane Sadou Yayé, Alain Astier, Muriel Paul, Thibaud Damy, Bernard Do
Publikováno v:
Antioxidants, Vol 12, Iss 2, p 424 (2023)
In vitro studies have shown that epigallocatechin gallate (EGCG), the most potent antioxidant of the green tea polyphenol catechins, is able to effectively prevent the formation of amyloid plaques and induce their clearance. However, its high chemica
Externí odkaz:
https://doaj.org/article/666c1f6220f941cb85f56b4679579456
Autor:
Philippe-Henri Secretan, Olivier Thirion, Hassane Sadou Yayé, Thibaud Damy, Alain Astier, Muriel Paul, Bernard Do
Publikováno v:
Pharmaceuticals, Vol 14, Iss 12, p 1242 (2021)
Because of its antioxidant, antimutagenic, and anti-infectious properties, epigallocatechin gallate (EGCG) is the most interesting compound among the green tea catechins polyphenols. However, its health effects are inconclusive due to its very low bi
Externí odkaz:
https://doaj.org/article/1a52ae2200de42d7a80b59ceeebf4ddf
Autor:
Xavier Jouven, Olivier Thirion, Marie Antignac, Philippe-Henri Secretan, Joël Schlatter, Hassane Sadou Yayé, Najet Yagoubi, Salvatore Cisternino, Bernard Do
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2021, 197, pp.113983. ⟨10.1016/j.jpba.2021.113983⟩
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2021, 197, pp.113983. ⟨10.1016/j.jpba.2021.113983⟩
Ruxolitinib is a Janus Kinase inhibitor currently approved for the treatment of myelofibrosis. It is also a promising drug for the treatment of skin and infectious diseases. In terms of pharmaceutical stability, although ruxolitinib has been establis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60136a12d4def77c5c141af48ea6895d
https://hal-univ-paris.archives-ouvertes.fr/hal-03244949
https://hal-univ-paris.archives-ouvertes.fr/hal-03244949
Autor:
Mylène Rollo, Pierre Wolkenstein, Olivier Thirion, Muriel Paul, Karine Andrieux, Guillaume Le Guyader, Victoire Vieillard
Publikováno v:
European Journal of Hospital Pharmacy
European Journal of Hospital Pharmacy, BMJ Group, 2018, 27 (e1), pp.e48-e52. ⟨10.1136/ejhpharm-2018-001695⟩
Eur J Hosp Pharm
European Journal of Hospital Pharmacy, BMJ Group, 2018, 27 (e1), pp.e48-e52. ⟨10.1136/ejhpharm-2018-001695⟩
Eur J Hosp Pharm
Objectives In recent years, various formulations containing rapamycin, mainly petrolatum-based, have been tested on facial angiofibromas in tuberous sclerosis. They are often poorly tolerated due to irritation and bleeding. In addition, their effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c548e242daa2710e6166da2e1fb07359
https://hal.archives-ouvertes.fr/hal-03041293/file/Article_VF.pdf
https://hal.archives-ouvertes.fr/hal-03041293/file/Article_VF.pdf
Autor:
Bernard Do, Victoire Vieillard, Philippe-Henri Secretan, Lionel Tortolano, Audrey Sogaldi, Marie Antignac, Hassane Sadou Yayé, Olivier Thirion, Najet Yagoubi
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 196:113934
Umifenovir is an antiviral drug approved in China and Russia for the treatment of influenza. The available dosage form consists of capsules marketed under the brand name Arbidol®. Due to its broad spectrum, umifenovir may also be used in other viral
Autor:
Violaine Nicolazo de Barmon, Line Jacob, François Pierrang, Jean Marty, Charlotte Chollet-Xemard, Etienne Audureau, David Schmitz, Oriane Augusto, Matthieu Heidet, Roland Amathieu, Amandine Rialland, Olivier Thirion
Publikováno v:
BMJ Open
IntroductionThe management of acute upper gastrointestinal bleeding (UGIB) is challenging in patients with cirrhosis, as it is responsible for severe complications and high mortality rates. Tranexamic acid (TXA) may help control the bleeding by count